(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.
Korro Bio's earnings in 2025 is -$91,355,000.On average, 7 Wall Street analysts forecast KRRO's earnings for 2025 to be -$96,350,665, with the lowest KRRO earnings forecast at -$105,272,023, and the highest KRRO earnings forecast at -$91,279,577. On average, 7 Wall Street analysts forecast KRRO's earnings for 2026 to be -$84,383,837, with the lowest KRRO earnings forecast at -$116,447,197, and the highest KRRO earnings forecast at -$57,472,326.
In 2027, KRRO is forecast to generate -$105,225,068 in earnings, with the lowest earnings forecast at -$145,558,997 and the highest earnings forecast at -$64,139,867.